Topline Results Of Phase III Study Of CicloMulsion For Acute Myocardial Infarction To Be Released in Q3
NeuroVive Pharmaceutical AB, a mitochondrial medicine firm, has indicated that it will announce the topline results of the company’s phase III CIRCUS study of CicloMulsion® in those suffering with ST-segment elevation acute myocardial infarction (STEMI), ... Read more